Jazz Pharms Inc Drug Patent Portfolio
Jazz Pharms Inc owns 1 orange book drug protected by 3 US patents Given below is the list of Jazz Pharms Inc's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11085043 | Euglobulin-based method for determining the biological activity of defibrotide | 22 Jun, 2032 | Active |
| US11236328 | Euglobulin-based method for determining the biological activity of defibrotide | 22 Jun, 2032 | Active |
| US11746348 | Euglobulin-based method for determining the biological activity of defibrotide | 22 Jun, 2032 | Active |
Latest Legal Activities on Jazz Pharms Inc's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Jazz Pharms Inc.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Patent eGrant Notification | 05 Sep, 2023 | US11746348 |
|
Email Notification
Critical
| 05 Sep, 2023 | US11746348 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 05 Sep, 2023 | US11746348 |
| Recordation of Patent eGrant | 05 Sep, 2023 | US11746348 |
| Mail Patent eGrant Notification | 05 Sep, 2023 | US11746348 |
|
Recordation of Patent Grant Mailed
Critical
| 05 Sep, 2023 | US11746348 |
|
Electronic Review
Critical
| 18 Aug, 2023 | US11746348 |
|
Email Notification
Critical
| 18 Aug, 2023 | US11746348 |
|
Issue Notification Mailed
Critical
| 16 Aug, 2023 | US11746348 |
| Dispatch to FDC | 27 Jul, 2023 | US11746348 |
|
Application Is Considered Ready for Issue
Critical
| 27 Jul, 2023 | US11746348 |
|
Email Notification
Critical
| 17 Jul, 2023 | US11746348 |
| Filing Receipt - Corrected | 17 Jul, 2023 | US11746348 |
|
Electronic Review
Critical
| 17 Jul, 2023 | US11746348 |
|
Issue Fee Payment Received
Critical
| 12 Jul, 2023 | US11746348 |
Jazz Pharms Inc Drug Patents' Oppositions Filed in EPO
Jazz Pharms Inc drug patents have faced multiple oppositions in the European Patent Office. The earliest opposition was filed on Aug 29, 2018, by Aechter, Bernd. This opposition was filed on patent number EP12756826A. Click below to reveal the latest opposition data.
| Application | Filing Date | Opposition Party | Legal Status |
|---|---|---|---|
 | |||
| EP12756826A | Aug, 2018 | Aechter, Bernd | Patent maintained as amended |
Jazz Pharms Inc's Family Patents
Jazz Pharms Inc Drug List
Given below is the complete list of Jazz Pharms Inc's drugs and the patents protecting them.
1. Defitelio
Defitelio is protected by 3 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11085043 | Euglobulin-based method for determining the biological activity of defibrotide |
22 Jun, 2032
(6 years from now)
| Active |
| US11236328 | Euglobulin-based method for determining the biological activity of defibrotide |
22 Jun, 2032
(6 years from now)
| Active |
| US11746348 | Euglobulin-based method for determining the biological activity of defibrotide |
22 Jun, 2032
(6 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Defitelio's drug page